This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

QAD On Demand Life Sciences Edition Makes It Easier For Medtech To Address The Challenges Of Globalization

QAD Inc. (NASDAQ:QADA) (NASDAQ:QADB) announced today it has seen increased deployments among Medical Technology ( Medtech) manufacturers for QAD On Demand Life Sciences Edition, the cloud enterprise resource planning (ERP) solution. QAD On Demand is full-strength cloud ERP that makes it easier for Medtech to meet globalization challenges and allocate capital for business initiatives and product innovation.

“Globalization has transformed demand for medical technology, accelerated production processes and given rise to new economies,” said Dave Medina, vice president of Life Sciences at QAD. “To meet today’s globalization challenges and opportunities, Medtech manufacturers are moving to the QAD global cloud ERP to benefit from its simplicity, reliability, global capabilities and predictable cost structure.”

QAD Cloud ERP Lets Medtech Focus on their Business and Product Innovation

QAD On Demand Life Sciences Edition offers the full suite of ERP capabilities and specific life sciences services to help QAD customers meet regulatory compliance. QAD cloud ERP allows Medtech manufacturers to focus on their business initiatives and product innovation – not their ERP software. The QAD cloud ERP model enables customers to eliminate capital expenditures associated with premise-based ERP software, hardware, system maintenance and support. QAD On Demand offers a robust and highly available solution. It is particularly scalable – and allows companies to standardize their ERP as they acquire new divisions, divest or pursue opportunities to rapidly scale operations in growth markets. QAD global capabilities with built-in support for local languages, currencies, business practices and legal requirements, enable Medtech manufacturers to efficiently align their global operations to strategic goals and perform at their best.

QAD Fully Qualified Cloud ERP – Built For Medical Technology Manufacturers

With QAD’s fully qualified IT environment and validation support tools, Medtech manufacturers can reduce the costs and effort of complying with regulatory requirements for software validation. QAD Life Science On Demand offers all the robust capabilities of QAD On Demand, but provides the necessary standard operating procedures (SOPs) required to meet requirements of the Food and Drug Administration (FDA), current Good Manufacturing Practices (cGMP) and 21 CFR Part 11.

Enhanced quality control capabilities in the QAD solution enhance product integrity across the global supply network -- from sourcing raw materials to distributing finished products -- with backward and forward traceability. This is particularly important for achieving regulatory requirements such as the emerging requirements for Unique Device Identification (UDI) compliance.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,024.06 +183.54 1.03%
S&P 500 2,108.29 +22.78 1.09%
NASDAQ 5,005.3910 +63.9670 1.29%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs